Correction to “Epiplakin1 promotes the progression of esophageal squamous cell carcinoma by activating the PI3K‐AKT signaling pathway”
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsLung Cancer Treatments and Mutations · PI3K/AKT/mTOR signaling in cancer · Kruppel-like factors research
Qiao Z, Dai C, Wang Z, Wang Z, Wang Z, Zhang T, et al. Epiplakin1 promotes the progression of esophageal squamous cell carcinoma by activating the PI3K‐AKT signaling pathway. Thorac Cancer. 2022;13:1117–1125. https://doi.org/10.1111/1759-7714.14366.
There was a mistake in the wound healing assay in Figure 4a. The revised figure is shown below:
We apologize for these errors.